These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31573421)

  • 21. Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries.
    Perehudoff K; Demchenko I; Alexandrov NV; Brutsaert D; Ackon A; Durán CE; El-Dahiyat F; Hafidz F; Haque R; Hussain R; Salenga R; Suleman F; Babar ZU
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33353250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to essential medicines in 195 countries: A human rights approach to sustainable development.
    Perehudoff SK; Alexandrov NV; Hogerzeil HV
    Glob Public Health; 2019 Mar; 14(3):431-444. PubMed ID: 30187828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health research prioritization in Somalia: setting the agenda for context specific knowledge to advance universal health coverage.
    Ssendagire S; Mohamoud SA; Bashir F; Jamal MA; Bulale M; Azad A; Warsame MY; Hassan F; Omar M; Dalmar A; Karanja MJ; Nyagah LM; Warsame A; Diriye AA; Malik SMMR
    Front Public Health; 2023; 11():1202034. PubMed ID: 38026320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa.
    Petricca K; Kambugu J; Githang'a J; Macharia WM; Njuguna F; McLigeyo A; Nyangasi M; Orem J; Kanyamuhunga A; Laiti R; Katabalo D; Schroeder K; Rogo K; Maguire B; Wambui L; Nkurunziza JN; Wong B; Neposlan J; Kilawe L; Gupta S; Denburg AE
    Lancet Oncol; 2023 May; 24(5):563-576. PubMed ID: 37023781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.
    Sharma A; Kaplan WA; Satheesh G; Poudyal IP; Gyawali P; Neupane D; Bhandari PM; Malla M; Sapkota S; Mishra SR
    Glob Heart; 2021 May; 16(1):38. PubMed ID: 34040951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in increasing affordability of medicines for non-communicable diseases since the introduction of mandatory health insurance in the Republic of Moldova.
    Ferrario A; Chitan E; Seicas R; Sautenkova N; Bezverhni Z; Kluge H; Habicht J
    Health Policy Plan; 2016 Jul; 31(6):793-800. PubMed ID: 26830363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico.
    Arredondo A; Azar A; Recaman AL
    Global Health; 2018 Aug; 14(1):89. PubMed ID: 30143010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS).
    Krishnan A; Mathur P; Kulothungan V; Salve HR; Leburu S; Amarchand R; Nongkynrih B; Chaturvedi HK; Ganeshkumar P; K S VU; Laxmaiah A; Boruah M; Kumar S; Patro BK; Raghav PR; Rajkumar P; Sarma PS; Sharma R; Tambe M; Arlappa N; Mahanta TG; Bhuyan PJ; Joshi RP; Pakhare AP; Galhotra A; Kumar D; Behera BK; Topno RK; Gupta MK; Rustagi N; Trivedi AV; Thankappan KR; Gupta S; Garg S; Shelke SC; ; ;
    BMC Health Serv Res; 2021 Jul; 21(1):757. PubMed ID: 34332569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The unfunded priorities: an evaluation of priority setting for noncommunicable disease control in Uganda.
    Essue BM; Kapiriri L
    Global Health; 2018 Feb; 14(1):22. PubMed ID: 29463270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Availability, prices and affordability of selected antibiotics and medicines against non-communicable diseases in western Cameroon and northeast DR Congo.
    Schäfermann S; Neci R; Ndze EN; Nyaah F; Pondo VB; Heide L
    PLoS One; 2020; 15(1):e0227515. PubMed ID: 31910444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
    Guan X; Hu H; Man C; Shi L
    Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel.
    Wells N; Chappuis F; Beran D
    Expert Rev Clin Pharmacol; 2020 Apr; 13(4):341-353. PubMed ID: 32155094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-system reform and universal health coverage in Latin America.
    Atun R; de Andrade LO; Almeida G; Cotlear D; Dmytraczenko T; Frenz P; Garcia P; Gómez-Dantés O; Knaul FM; Muntaner C; de Paula JB; Rígoli F; Serrate PC; Wagstaff A
    Lancet; 2015 Mar; 385(9974):1230-47. PubMed ID: 25458725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
    Todesco B; Ostuzzi G; Barbui C
    Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global access to affordable direct oral anticoagulants.
    Neumann I; Schünemann HJ; Bero L; Cooke G; Magrini N; Moja L
    Bull World Health Organ; 2021 Sep; 99(9):653-660. PubMed ID: 34475602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
    Dabare PR; Wanigatunge CA; Beneragama BH
    BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of the French Muskoka Fund to improving access to essential medicines and priority health products for mothers and children.
    Macé C; Nikiema JB
    Med Sante Trop; 2016 Nov; 26(4):367-370. PubMed ID: 28073721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Availability and affordability of antimalarial and antibiotic medicines in Malawi.
    Khuluza F; Heide L
    PLoS One; 2017; 12(4):e0175399. PubMed ID: 28419126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which UHC? Features for Equity and Universalism Comment on "Universal Health Coverage for Non-Communicable Diseases and Health Equity: Lessons From Australian Primary Healthcare".
    Loewenson R
    Int J Health Policy Manag; 2022 May; 11(5):704-707. PubMed ID: 34380201
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.